---All---
  • ---All---
  • Accession
  • Catalog #

MAPILC3A Antibody (C-term)Rabbit Monoclonal Antibody

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1456b 100ul 400 ul 2-3 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

MAPILC3A Antibody (C-term) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9H492
ReactivityHuman, Mouse, Rat
Clone NamesEP1983Y
Calculated MW14272 Da
Gene ID 84557
Other Names
MAP1LC3A, Microtubule-associated proteins 1A/1B light chain 3A, Microtubule-associated protein 1 light chain 3 alpha;MAP1A/1B light chain 3 A;MAP1A/MAP1B LC3 A;MAP1 light chain 3-like protein 1;Autophagy-related protein LC3 A;Autophagy-related ubiquitin-like modifier LC3 A
Target/Specificity
A synthetic peptide corresponding to residues on the C-terminus of human MAPILC3A was used as an immunogen.
Dilution
WB~~1:10000
IHC~~1:100~250
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
MAPILC3A Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

MAPILC3A Antibody (C-term) - Protein Information

Name MAP1LC3A
Function
Involved in formation of autophagosomal vacuoles (autophagosomes)
Cellular Location
Cytoplasm, cytoskeleton. Endomembrane system; Lipid-anchor. Cytoplasmic vesicle, autophagosome membrane; Lipid-anchor. Cytoplasmic vesicle, autophagosome. Note=LC3-II binds to the autophagic membranes
Tissue Location
Most abundant in heart, brain, liver, skeletal muscle and testis but absent in thymus and peripheral blood leukocytes

MAPILC3A Antibody (C-term) - Related products

AM1800a: LC3 Antibody (APG8)

AM1823a: APG8a (MAP1LC3A)-S12 Antibody

AP1800a: LC3 Antibody (APG8A)

AP1801a: LC3 Antibody (APG8A) (N-term)

AP1801b: LC3 Antibody (APG8A) (P45)

AP1801c: LC3 Antibody (APG8A) (I31)

AP1801d: LC3 Antibody (APG8A) (D106)

AP1801e: LC3 Antibody (APG8A) (S12)

AP1801f: LC3 Antibody (APG8A) (S3)

AP1801g: LC3 Antibody (APG8A) (T93/Y99)

AP1801h: LC3 Antibody (APG8A) (T93/Y99)

AP1801i: LC3 Antibody (Isoform B Specific)

AP1805a: Cleaved LC3A Antibody

AP3301a: Phospho-LC3C-S12 Antibody

AP3620a: Phospho-LC3A-T93 Antibody

AP3641a: Phospho-LC3A-S3 Antibody

AP3706a: Phospho-APG8a (MAP1LC3A)-Y99 Antibody

RI13150: MAP1LC3A predesign siRNA

BP1801a: LC3 Antibody (APG8a) (N-term) Blocking Peptide

BP1801b: LC3 (APG8a) Antibody (P45) Blocking Peptide

BP1801c: LC3 Antibody (APG8a) (I31) Blocking Peptide

BP1801d: LC3 Antibody (APG8a) (D106) Blocking Peptide

BP1801e: APG8a (MAP1LC3A) Antibody (S12) Blocking Peptide

BP1801f: APG8a (MAP1LC3A) Antibody (S3) Blocking Peptide

BP1801g: APG8a (MAP1LC3A) Antibody (T93/Y99) Blocking Peptide

BP1801h: APG8a (MAP1LC3A) Antibody (T93/Y99) Blocking Peptide

BP1801i: APG8a (MAP1LC3A) Antibody (Isoform b specific) Blocking Peptide

BP1805a: Cleaved-LC3 Antibody (APG8a) Blocking Peptide

BP3301a: Phospho-LC3 (APG8a) - S12 Antibody Blocking Peptide

BP3620a: Phospho-APG8a (MAP1LC3A)-pT93 Antibody Blocking Peptide

BP3641a: Phospho-APG8a (MAP1LC3A)-pS3 Antibody Blocking Peptide

BP3706a: Phospho-APG8a(MAP1LC3A)-Y99 Antibody Blocking Peptide

AJ1456a: MAPILC3A Antibody

AJ1456b: MAPILC3A Antibody (C-term)

AJ1456c: MAPILC3A Antibody (N-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Microtubule-associated MAPILC3A constitute nearly half of the mass of all the microtubule associated proteins that copurify with brain microtubules. MAPILC3A is composed of a heavy chain and multiple light-chain subunits. Amino acid sequencing of a 120 kd microtubule-binding and light chain-binding fragment of the heavy chain reveals that light chain 1 binds near the heavy chain N-terminus. These data indicate that the heavy chain and light chain 1 are produced by proteolytic processing of a MAP1B polyprotein and form a complex microtubule-binding domain (1). There are three human orthologs of the rat Map1LC3, named MAP1LC3A, MAP1LC3B, and MAP1LC3C. The three isoforms of human MAP1LC3 exhibit distinct expression patterns in different human tissues and also differ in their post-translation modifications. MAP1LC3A and MAP1LC3C are produced by the proteolytic cleavage after the conserved C-terminal Gly residue; MAP1LC3B does not undergo C-terminal cleavage and exists in a single modified form (2).

REFERENCES

1. Hammarback JA, et al. Neuron 7(1):129-39, 1991.
2. He H, et al. J. Biol Chem 278(31):29278-87, 2003.